Cingulate has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $7,500,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Cingulate is raising $7,500,000.00 in new funding. About Cingulate: Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment…
